Amit Sachdev, EVP Chief Patient & Ext Af Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 58,613 shares at $463.91 ($27.5M) on 2026-02-19, disclosed to the SEC on 2026-02-23.
Seasonal sale ($27.5M) by EVP Chief Patient & Ext Af Officer — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $463.91 | 920 | $427K | 1.6% |
| 2 | $465.05 | 2,730 | $1.3M | 4.6% |
| 3 | $465.80 | 1,848 | $861K | 3.1% |
| 4 | $467.75 | 10,263 | $4.8M | 17.5% |
| 5 | $468.57 | 19,662 | $9.2M | 33.5% |
| 6 | $469.61 | 7,241 |
| $3.4M |
| 12.4% |
| 7 | $470.54 | 11,712 | $5.5M | 20.1% |
| 8 | $471.43 | 4,237 | $2.0M | 7.3% |
| Total | $468.83 avg | 58,613 | $27.5M | 100% |
| Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |
| VRTX | SELL | 2024-02-21 | $3.6M | — | Filing → |